StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/302% above fair value
$14.79+0.00 (0.00%)

Close on Nov 17, 2026Market cap $294.58MP/E 36.1Yield –

InfuSystem operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

InfuSystem's operating cash flow for the twelve months ending Jun 30, 2026 was $23.37M, down 12.0% year over year. For fiscal 2025 it was $24.41M, up 19.3% from the year before. Over ten years it grew 13.2% a year on average. The highest annual figure on record is $24.41M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.41M+19.3%
FY2024Dec 31, 2024$20.46M+82.3%
FY2023Dec 31, 2023$11.22M-35.9%
FY2022Dec 31, 2022$17.52M-4.4%
FY2021Dec 31, 2021$18.32M-9.7%
FY2020Dec 31, 2020$20.28M+46.2%
FY2019Dec 31, 2019$13.88M+21.8%
FY2018Dec 31, 2018$11.39M+47.6%
FY2017Dec 31, 2017$7.72M-2.4%
FY2016Dec 31, 2016$7.91M+12.1%
FY2015Dec 31, 2015$7.05M-2.8%
FY2014Dec 31, 2014$7.26M-2.8%
FY2013Dec 31, 2013$7.46M+36.9%
FY2012Dec 31, 2012$5.45M-19.2%
FY2011Dec 31, 2011$6.75M-37.6%
FY2010Dec 31, 2010$10.81M+11.4%
FY2009Dec 31, 2009$9.71M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$6.78M-3.3%
Q1 FY2026Mar 31, 2026$970.00K-45.5%
Q4 FY2025Dec 31, 2025$7.13M-10.2%
Q3 FY2025Sep 30, 2025$8.49M-13.7%
Q2 FY2025Jun 30, 2025$7.01M+203.6%
Q1 FY2025Mar 31, 2025$1.78M+372.1%
Q4 FY2024Dec 31, 2024$7.93M+70.3%
Q3 FY2024Sep 30, 2024$9.84M+130.8%
Q2 FY2024Jun 30, 2024$2.31M-5.8%
Q1 FY2024Mar 31, 2024$377.00K–
Q4 FY2023Dec 31, 2023$4.66M+2.0%
Q3 FY2023Sep 30, 2023$4.26M+23.4%
Q2 FY2023Jun 30, 2023$2.45M-54.7%
Q1 FY2023Mar 31, 2023-$151.00K-103.7%
Q4 FY2022Dec 31, 2022$4.57M+23.0%
Q3 FY2022Sep 30, 2022$3.46M-40.3%
Q2 FY2022Jun 30, 2022$5.42M-12.1%
Q1 FY2022Mar 31, 2022$4.08M+53.8%
Q4 FY2021Dec 31, 2021$3.71M-51.2%
Q3 FY2021Sep 30, 2021$5.79M-31.1%
Q2 FY2021Jun 30, 2021$6.16M+66.3%
Q1 FY2021Mar 31, 2021$2.65M+375.9%
Q4 FY2020Dec 31, 2020$7.61M+75.4%
Q3 FY2020Sep 30, 2020$8.41M+61.2%
Q2 FY2020Jun 30, 2020$3.71M+21.5%
Q1 FY2020Mar 31, 2020$557.00K-56.1%
Q4 FY2019Dec 31, 2019$4.34M+36.5%
Q3 FY2019Sep 30, 2019$5.22M+55.0%
Q2 FY2019Jun 30, 2019$3.05M-19.6%
Q1 FY2019Mar 31, 2019$1.27M+20.5%
Q4 FY2018Dec 31, 2018$3.18M-12.0%
Q3 FY2018Sep 30, 2018$3.36M+17.2%
Q2 FY2018Jun 30, 2018$3.79M+41.9%
Q1 FY2018Mar 31, 2018$1.05M–
Q4 FY2017Dec 31, 2017$3.62M-13.4%
Q3 FY2017Sep 30, 2017$2.87M+53.9%
Q2 FY2017Jun 30, 2017$2.67M–
Q1 FY2017Mar 31, 2017-$1.44M–
Q4 FY2016Dec 31, 2016$4.17M–
Q3 FY2016Sep 30, 2016$1.87M–

More InfuSystem figures

See a number that looks wrong?